Structures by: Cobo J.
Total: 558
2-amino-4,6-bis[N-methyl-N-(4-methylphenyl)amino]pyrimidine-5-carbaldehyde
C21H23N5O
Acta Crystallographica Section C (2007) 63, 11 o681-o684
a=8.6844(6)Å b=10.7807(19)Å c=10.8903(10)Å
α=69.998(14)° β=88.918(7)° γ=76.822(13)°
2-amino-4-(indolin-1-yl)-6-methoxypyrimidine-5-carbaldehyde
C14H14N4O2
Acta Crystallographica Section C (2007) 63, 11 o681-o684
a=8.2846(4)Å b=11.2710(4)Å c=15.0024(7)Å
α=108.983(4)° β=95.403(4)° γ=101.908(3)°
<i>N</i>-(3-<i>tert</i>-Butyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)-<i>N</i>- (4-methoxybenzyl)acetamide
C23H27N3O2
Acta Crystallographica Section C (2010) 66, 2 o64-o66
a=9.8325(3)Å b=9.8649(4)Å c=12.0365(3)Å
α=97.468(2)° β=95.512(2)° γ=114.6430(10)°
3-hydroxy-3-[(4-methylbenzoyl)methyl]indolin-2-one
C17H15NO3
Acta Crystallographica Section C (2010) 66, 2 o79-o86
a=6.873(2)Å b=7.6700(17)Å c=13.394(5)Å
α=99.48(2)° β=101.68(3)° γ=96.33(2)°
3-hydroxy-3-[(4-fluorobenzoyl)methyl]indolin-2-one
C16H12FNO3
Acta Crystallographica Section C (2010) 66, 2 o79-o86
a=6.8858(7)Å b=7.7074(8)Å c=12.7010(9)Å
α=98.229(7)° β=103.667(7)° γ=96.034(9)°
3-hydroxy-3-[(4-chlorobenzoyl)methyl]indolin-2-one
C16H12ClNO3
Acta Crystallographica Section C (2010) 66, 2 o79-o86
a=6.987(2)Å b=7.689(4)Å c=12.907(4)Å
α=99.30(3)° β=101.82(4)° γ=96.33(3)°
3-[(4-bromobenzoyl)methyl]-3-hydroxyindolin-2-one
C16H12BrNO3
Acta Crystallographica Section C (2010) 66, 2 o79-o86
a=7.016(3)Å b=7.7349(12)Å c=13.052(6)Å
α=99.69(3)° β=101.51(4)° γ=96.70(3)°
3-hydroxy-3-[(4-nitrobenzoyl)methyl]indolin-2-one
C16H12N2O5
Acta Crystallographica Section C (2010) 66, 2 o79-o86
a=7.0260(10)Å b=7.598(3)Å c=13.365(4)Å
α=97.54(3)° β=102.67(2)° γ=96.46(2)°
3-hydroxy-3-(2-thienylcarbonylmethyl)indolin-2-one
C14H11NO3S
Acta Crystallographica Section C (2010) 66, 2 o79-o86
a=6.5958(7)Å b=7.9577(14)Å c=12.045(3)Å
α=78.51(2)° β=76.555(13)° γ=84.559(15)°
<i>O</i>-ethyl (4-methylbenzoyl)thiocarbamate
C11H13NO2S
Acta Crystallographica Section C (2010) 66, 3 o141-o146
a=12.2845(14)Å b=9.1431(17)Å c=9.7897(4)Å
α=90.00° β=90.182(7)° γ=90.00°
<i>O</i>,<i>S</i>-diethyl (4-methylbenzoyl)imidothiocarbonate
C13H17NO2S
Acta Crystallographica Section C (2010) 66, 3 o141-o146
a=7.2470(16)Å b=8.8870(7)Å c=10.7370(10)Å
α=100.691(7)° β=99.984(13)° γ=107.307(11)°
<i>O</i>-ethyl benzoylthiocarbamate
C10H11NO2S
Acta Crystallographica Section C (2010) 66, 3 o141-o146
a=9.9418(8)Å b=9.3619(5)Å c=10.9337(13)Å
α=90.00° β=90.00° γ=90.00°
<i>O</i>,<i>S</i>-diethyl (4-chlorobenzoyl)imidothiocarbonate
C12H14ClNO2S
Acta Crystallographica Section C (2010) 66, 3 o141-o146
a=7.8028(14)Å b=9.480(2)Å c=9.860(2)Å
α=69.545(13)° β=75.683(14)° γ=69.548(15)°
(<i>E</i>)-<i>N</i>-{[6-Chloro-4-(4-chlorophenyl)-3-methyl-1-phenyl-1<i>H</i>- pyrazolo[3,4-<i>b</i>]pyridin-5-yl]methylene}benzene-1,2-diamine
C26H19Cl2N5
Acta Crystallographica Section C (2010) 66, 3 o137-o140
a=10.013(2)Å b=12.3487(12)Å c=17.666(4)Å
α=90.00° β=90.00° γ=90.00°
7,9-dichloro-2-<i>exo</i>-(prop-1-en-2-yl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C13H13Cl2NO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=10.4753(13)Å b=5.4759(8)Å c=10.9632(12)Å
α=90.00° β=105.791(13)° γ=90.00°
6-(4-bromophenyl)-3-methyl-1-phenyl-4,5-dihydro-1<i>H</i>- pyrazolo[3,4-<i>b</i>]pyridine
C19H16BrN3
Acta Crystallographica Section C (2010) 66, 4 o163-o167
a=7.51650(10)Å b=11.6572(3)Å c=17.6917(5)Å
α=90.00° β=92.701(2)° γ=90.00°
7-Amino-5-methyl-2-phenyl-6-(phenyldiazenyl)pyrazolo[1,5-<i>a</i>]pyrimidine
C19H16N6
Acta Crystallographica Section C (2010) 66, 3 o133-o136
a=9.6342(13)Å b=33.216(5)Å c=9.747(3)Å
α=90.00° β=90.237(18)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-2-<i>exo</i>-vinyl-2,3,4,5-tetrahydro-1<i>H</i>- 1,4-epoxy-1-benzazepine
C12H13NO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=9.8070(13)Å b=7.3982(7)Å c=13.738(2)Å
α=90.00° β=105.441(11)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-8-chloro-9-methyl-2-<i>exo</i>-(2-methylprop-1-enyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C15H18ClNO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=11.0631(7)Å b=5.7212(5)Å c=21.203(6)Å
α=90.00° β=102.587(16)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-8-chloro-9-methyl-2-<i>exo</i>-(prop-1-en-2-yl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C14H16ClNO
Acta Crystallographica Section C (2010) 66, 4 o209-o214
a=8.6828(11)Å b=10.1456(6)Å c=14.2976(16)Å
α=90.000° β=107.587(9)° γ=90.000°
3-(4-nitrophenyl)-4-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine
C18H12N4O2
Acta Crystallographica Section C (2010) 66, 4 o163-o167
a=7.04080(10)Å b=9.6360(3)Å c=11.1961(3)Å
α=84.9060(10)° β=89.177(2)° γ=81.012(2)°
2-exo-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C16H15NO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=10.7475(7)Å b=10.7842(12)Å c=20.5812(19)Å
α=90.00° β=91.688(7)° γ=90.00°
Rac-3-(5-Amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-phenyl-thiazolidin-4-one
C19H18N4OS
Acta Crystallographica Section C (2004) 60, 7 o486-o488
a=10.7937(4)Å b=11.3989(2)Å c=14.2448(5)Å
α=79.993(2)° β=83.3490(14)° γ=89.852(2)°
S-Ethyl N-benzoyldithiocarbamate
C10H11NOS2
Acta Crystallographica Section C (2004) 60, 7 o483-o485
a=21.8190(5)Å b=8.4596(2)Å c=23.1792(5)Å
α=90.00° β=94.5140(14)° γ=90.00°
9-(4-Chlorophenyl)-7-methyl-5,6-dihydrobenzo[h]pyrazolo[3,2-b]quinazoline
C21H16ClN3
Acta Crystallographica Section C (2004) 60, 8 o604-o607
a=9.2382(8)Å b=10.3054(8)Å c=10.3184(9)Å
α=62.720(4)° β=83.098(4)° γ=70.531(5)°
2-(4-Chlorophenyl)-5-methyl-6,7-dihydrobenzo[e]pyrazolo[2,3-b]quinazoline
C21H16ClN3
Acta Crystallographica Section C (2004) 60, 8 o604-o607
a=7.0098(3)Å b=15.0306(7)Å c=17.0060(8)Å
α=111.492(2)° β=101.406(3)° γ=97.981(3)°
Methyl 1-benzyl-2-(4-chlorophenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C22H17ClN2O2
Acta Crystallographica Section C (2013) 69, 1 77-81
a=14.214(2)Å b=11.7391(10)Å c=11.0580(14)Å
α=90.00° β=98.908(10)° γ=90.00°
(<i>Z</i>)-5-[4-(Dimethylamino)benzylidene]-2-(piperidin-1-yl)- 1,3-thiazolidin-4(5<i>H</i>)-one
C17H21N3OS
Acta Crystallographica Section C (2013) 69, 1 74-76
a=12.7125(14)Å b=7.8246(4)Å c=16.579(2)Å
α=90.00° β=106.904(9)° γ=90.00°
Methyl 4-(4-chloroanilino)-3-nitrobenzoate
C14H11ClN2O4
Acta Crystallographica Section C (2013) 69, 1 77-81
a=12.4413(10)Å b=15.8116(18)Å c=7.1805(10)Å
α=90.00° β=103.037(9)° γ=90.00°
(<i>2RS</i>,4<i>SR</i>)-2-(5-bromothiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxynaphtho[1,2-<i>b</i>]azepine
C18H14BrNOS
Acta Crystallographica Section C (2013) 69, 3 307-312
a=15.316(2)Å b=9.9230(18)Å c=20.225(3)Å
α=90.000° β=90.000° γ=90.000°
Ethyl 3-amino-<i>N</i>-{2-amino-5-formyl-6-[methyl(phenyl)amino]pyrimidin- 4-yl}propionate
C17H21N5O3
Acta Crystallographica Section C (2013) 69, 2 162-171
a=16.707(6)Å b=10.218(2)Å c=20.733(5)Å
α=90.00° β=105.929(19)° γ=90.00°
Ethyl <i>N</i>-{2-amino-5-formyl-6-[methyl(phenyl)amino]pyrimidin-4-yl}glycinate
C16H19N5O3
Acta Crystallographica Section C (2013) 69, 2 162-171
a=7.3990(5)Å b=9.609(3)Å c=12.449(3)Å
α=73.30(2)° β=82.680(14)° γ=72.693(13)°
Methyl <i>N</i>-{2-amino-6-[benzyl(methyl)amino]-5-formylpyrimidin-4-yl}glycinate
C16H19N5O3
Acta Crystallographica Section C (2013) 69, 2 162-171
a=15.636(4)Å b=6.5674(18)Å c=17.336(5)Å
α=90.00° β=113.440(18)° γ=90.00°
Ethyl 3-amino-<i>N</i>-[2-amino-5-formyl-6-(piperidin-4-yl)pyrimidin-4-yl]propionate
C15H23N5O3
Acta Crystallographica Section C (2013) 69, 2 162-171
a=8.040(4)Å b=10.391(3)Å c=10.458(8)Å
α=109.16(3)° β=98.19(5)° γ=103.10(3)°
(2<i>R</i>,4<i>S</i>)-2-(3-Methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxynaphtho[1,2-<i>b</i>]-azepine
C19H17NOS
Acta Crystallographica Section C (2013) 69, 3 307-312
a=7.0387(3)Å b=11.5605(10)Å c=18.1951(17)Å
α=90.00° β=90.00° γ=90.00°
5-Methyl-<i>N</i>-[2-nitro-4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazole- 3-amine
C11H9F3N4O2
Acta Crystallographica Section C (2013) 69, 2 172-174
a=4.957(2)Å b=8.737(3)Å c=13.562(5)Å
α=93.22(3)° β=97.02(3)° γ=91.05(3)°
(2<i>RS</i>,4<i>SR</i>)-2-(5-Methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy-naphtho[1,2-<i>b</i>]azepine
C19H17NOS
Acta Crystallographica Section C (2013) 69, 3 307-312
a=16.165(2)Å b=5.2505(3)Å c=20.0410(19)Å
α=90.00° β=118.813(9)° γ=90.00°
(<i>E</i>)-2-(1,3-Benzothiazol-2-yl)-3-(4-fluorophenyl)acrylonitrile
C16H9FN2S
Acta Crystallographica Section C (2013) 69, 6 671-673
a=8.2432(12)Å b=13.327(3)Å c=11.6819(19)Å
α=90.00° β=99.743(11)° γ=90.00°
4-(2-Chlorophenyl)pyrrolo[1,2-<i>a</i>]quinoxaline
C17H11ClN2
Acta Crystallographica Section C (2013) 69, 5 544-548
a=13.5649(13)Å b=11.8142(11)Å c=8.1678(12)Å
α=90.00° β=99.281(10)° γ=90.00°
(<i>RS</i>)-4-(1,3-Benzodioxol-6-yl)-4,5-dihydropyrrolo[1,2-<i>a</i>]quinoxaline
C18H14N2O2
Acta Crystallographica Section C (2013) 69, 5 544-548
a=26.590(3)Å b=6.2890(9)Å c=17.2655(19)Å
α=90.00° β=104.017(11)° γ=90.00°
Methyl 4-[2-(2-fluorobenzoyl)hydrazino]-3-nitrobenzoate
C15H12FN3O5
Acta Crystallographica Section C (2013) 69, 7 754-760
a=4.5445(6)Å b=16.5768(8)Å c=19.812(2)Å
α=90.00° β=92.107(9)° γ=90.00°
Methyl 3-phenyl-1,2,4-benzotriazine-6-carboxylate
C15H11N3O2
Acta Crystallographica Section C (2013) 69, 7 754-760
a=5.9193(14)Å b=28.138(2)Å c=7.3091(8)Å
α=90.00° β=94.762(14)° γ=90.00°
Methyl 3-(4-methylphenyl)-1,2,4-benzotriazine- 6-carboxylate
C16H13N3O2
Acta Crystallographica Section C (2013) 69, 7 754-760
a=7.2326(4)Å b=12.3516(13)Å c=29.695(3)Å
α=90.00° β=90.00° γ=90.00°
3-Amino-4-anilino-1<i>H</i>-isochromen-1-one
C15H12N2O2
Acta Crystallographica Section C (2013) 69, 7 770-773
a=10.157(2)Å b=5.7147(5)Å c=21.208(3)Å
α=90.00° β=105.048(15)° γ=90.00°
3-Amino-4-[methyl(phenyl)amino]-1<i>H</i>-isochromen-1-one
C16H14N2O2
Acta Crystallographica Section C (2013) 69, 7 770-773
a=14.5018(15)Å b=7.7796(8)Å c=11.608(2)Å
α=90.00° β=95.728(13)° γ=90.00°
Dibenzylammonium hydrogen maleate
C14H16N,C4H3O4
Acta Crystallographica Section C (2013) 69, 7 798-802
a=5.7551(5)Å b=16.1579(19)Å c=17.1230(19)Å
α=90.00° β=95.464(8)° γ=90.00°
Bis(dibenzylamino)methane
C29H30N2
Acta Crystallographica Section C (2013) 69, 7 798-802
a=25.548(6)Å b=12.9426(16)Å c=18.555(3)Å
α=90.00° β=130.428(11)° γ=90.00°
7-Benzyl-3-<i>tert</i>-butyl-1-phenyl-4,5,6,7-tetrahydro-1<i>H</i>-spiro[pyrazolo[3,4-<i>b</i>]pyridine-5,2'-indan]-1',3'-dione
C31H29N3O2
Acta Crystallographica Section C (2013) 69, 8 884-887
a=16.6917(18)Å b=5.9748(4)Å c=24.840(3)Å
α=90.00° β=91.841(10)° γ=90.00°
Methyl (1<i>RS</i>,3<i>SR</i>,3a<i>RS</i>,6a<i>SR</i>)-1-methyl-3-(3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)-4,6-dioxo-5-phenyloctahydropyrrolo[3,4-<i>c</i>]pyrrole-1-carboxylate
C25H24N4O4
Acta Crystallographica Section C (2013) 69, 8 915-919
a=11.355(2)Å b=20.025(4)Å c=10.4124(8)Å
α=90.00° β=110.030(9)° γ=90.00°
Methyl (1<i>RS</i>,3<i>SR</i>,3a<i>RS</i>,6a<i>SR</i>)-5-(4-chlorophenyl)-1-methyl-3-(3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)-4,6-dioxooctahydropyrrolo[3,4-<i>c</i>]pyrrole-1-carboxylate
C25H23ClN4O4
Acta Crystallographica Section C (2013) 69, 8 915-919
a=16.565(3)Å b=6.9529(5)Å c=21.010(4)Å
α=90.00° β=110.465(11)° γ=90.00°
Methyl 4-[2-(4-chlorobenzoyl)hydrazino]-3-nitrobenzoate
C15H12ClN3O5
Acta Crystallographica Section C (2013) 69, 7 754-760
a=4.7546(5)Å b=6.1071(14)Å c=25.541(5)Å
α=90.00° β=93.686(12)° γ=90.00°
2-Amino-4-methoxy-6-(4-methoxyphenyl)-11<i>H</i>-pyrimido[4,5- <i>b</i>][1,4]benzodiazepine
C19H17N5O2
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=7.6718(18)Å b=13.2928(15)Å c=15.969(2)Å
α=90.00° β=95.343(12)° γ=90.00°
2-Amino-4-methoxy-6-phenyl-11<i>H</i>-pyrimido[4,5-<i>b</i>][1,4]benzodiazepine
C18H15N5O
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=7.022(6)Å b=12.855(9)Å c=16.199(8)Å
α=90.00° β=93.851(5)° γ=90.00°
3-<i>tert</i>-butyl-7-(2,3-dimethoxybenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione
C32H39N3O4
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=12.4683(15)Å b=10.2892(12)Å c=21.7635(16)Å
α=90.00° β=90.843(10)° γ=90.00°
3-<i>tert</i>-butyl-4',4'-dimethyl-7-(3,4-methylenedioxobenzyl)-1-phenyl- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione
C31H35N3O4
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=9.2691(14)Å b=11.0898(11)Å c=12.802(2)Å
α=92.844(10)° β=95.185(12)° γ=91.070(11)°
3-<i>tert</i>-butyl-1-phenyl-7-(4-trifluoromethylbenzyl)-4,5,6,7-tetrahydro- 1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane-2',6'-dione
C29H30F3N3O2
Acta Crystallographica Section C (2008) 64, 12 o671-o674
a=11.9298(18)Å b=10.5678(10)Å c=19.614(2)Å
α=90.00° β=96.627(10)° γ=90.00°
3-<i>tert</i>-butyl-7-(4-methoxybenzyl)-1-phenyl-4,5,6,7-tetrahydro- 1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane-2',6'-dione
C29H33N3O3
Acta Crystallographica Section C (2008) 64, 12 o671-o674
a=9.1904(10)Å b=11.9402(14)Å c=22.2888(16)Å
α=90.00° β=97.287(9)° γ=90.00°
(1RS,2SR,3RS,5SR)-2-Benzoyl-4,4-dicyano-1,3,5-triphenylcyclohexanol
C33H26N2O2
Acta Crystallographica Section C (2008) 64, 10 o578-o582
a=10.9251(18)Å b=11.777(3)Å c=11.9438(12)Å
α=90.417(13)° β=112.616(9)° γ=112.750(14)°
3-<i>tert</i>-Butyl-4',4'-dimethyl-7-(4-methylbenzyl)-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione ethanol hemisolvate
C31H37N3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.281(5)Å b=10.6438(15)Å c=21.567(3)Å
α=90.00° β=122.082(12)° γ=90.00°
3-<i>tert</i>-Butyl-4',4'-dimethyl-1-phenyl-7-[4-(trifluoromethyl)benzyl]- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione ethanol hemisolvate
C31H34F3N3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=10.3270(12)Å b=11.9970(14)Å c=12.427(3)Å
α=75.016(13)° β=70.059(11)° γ=84.481(9)°
2-Amino-4-methoxy-6-(2-fluorophenyl)-11<i>H</i>-pyrimido[4,5- <i>b</i>][1,4]benzodiazepine
C18H14FN5O
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=6.9115(10)Å b=12.8801(14)Å c=16.560(2)Å
α=90.00° β=95.110(10)° γ=90.00°
2-Amino-4-methoxy-6-(3-nitrophenyl)-11<i>H</i>-pyrimido[4,5- <i>b</i>][1,4]benzodiazepine
C18H14N6O3
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=7.047(4)Å b=13.502(7)Å c=16.418(5)Å
α=90.00° β=91.22(5)° γ=90.00°
3-<i>tert</i>-butyl-4',4'-dimethyl-1-phenyl-7-(3,4,5-trimethoxybenzyl)- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione ethanol 0.67-solvate
C33H41N3O5,0.67(C2H6O)
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=13.5770(17)Å b=17.476(3)Å c=26.670(3)Å
α=90.00° β=90.00° γ=90.00°
3-<i>tert</i>-Butyl-7-(4-chlorobenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione ethanol hemisolvate
C30H34ClN3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.419(4)Å b=10.5860(13)Å c=21.580(3)Å
α=90.00° β=122.625(11)° γ=90.00°
3-<i>tert</i>-Butyl-7-(4-bromobenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione ethanol hemisolvate
C30H34BrN3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.4453(7)Å b=10.5519(8)Å c=21.715(2)Å
α=90.00° β=122.484(7)° γ=90.00°
1-(6-amino-1,3-benzodioxol-5-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C19H19NO6
Acta Crystallographica Section C (2002) 58, 1 o42-o45
a=23.5477(4)Å b=4.96050(10)Å c=14.2556(8)Å
α=90° β=100.7020(10)° γ=90°
1-(6-amino-1,3-benzodioxol-5-yl)-3-[4-(N,N-dimethylamino)phenyl]prop-2-en-1-one
C18H18N2O3
Acta Crystallographica Section C (2002) 58, 1 o42-o45
a=9.5849(2)Å b=12.3218(4)Å c=13.3304(4)Å
α=83.4617(14)° β=80.2411(17)° γ=85.7271(16)°
5-(3-(4-methylphenyl)-2-propenylidene]-2,2-dimethyl-[1,3] dioxane-4,6-dione
C16H16O4
Acta Crystallographica Section C (2002) 58, 1 o39-o41
a=11.2891(3)Å b=11.4128(4)Å c=13.4504(5)Å
α=91.217(2)° β=114.640(3)° γ=113.7590(15)°
5-(3-(4-chlorophenyl)-2-propenylidene]-2,2-dimethyl-[1,3] dioxane-4,6-dione
C15H13ClO4
Acta Crystallographica Section C (2002) 58, 1 o39-o41
a=7.2648(2)Å b=7.4705(3)Å c=13.5855(6)Å
α=90.1799(13)° β=99.8452(14)° γ=109.576(3)°
4-(4-Chlorophenyl)-3,7,7-trimethyl-1-[2-(4-nitrobenzoyl)ethyl]-4,7,8,9- tetrahydro-1H-pyrazolo[3,4-b]quinolin-5(6H)-one-ethanol (1/1)
C28H27ClN4O4,C2H6O
Acta Crystallographica Section C (2001) 57, 11 1356-1358
a=23.6298(6)Å b=9.6215(3)Å c=14.2657(4)Å
α=90° β=120.2930(16)° γ=90°
2-amino-6-[methyl(phenyl)amino]-5-[(E)-4-nitrobenzylideneamino]pyrimidin- 4(3<i>H</i>)-one dimethyl sulfoxide solvate
C18H16N6O3,C2H6OS
Acta Crystallographica Section C (2009) 65, 3 o111-o114
a=10.2601(8)Å b=10.4555(6)Å c=11.4537(14)Å
α=113.230(7)° β=112.295(8)° γ=96.709(8)°
1,3-dimethyl-7-(4-methylphenyl)pyrido[2,3-<i>d</i>]pyrimidine- 2,4(1<i>H</i>,3<i>H</i>)-dione
C16H15N3O2
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=6.9953(5)Å b=7.9221(7)Å c=12.5140(13)Å
α=93.466(4)° β=92.993(6)° γ=101.152(6)°
7-(biphenyl-4-yl)-1,3-dimethylpyrido[2,3-<i>d</i>]pyrimidine- 2,4(1<i>H</i>,3<i>H</i>)-dione
C21H17N3O2
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=7.2314(5)Å b=17.5834(18)Å c=12.4864(15)Å
α=90.00° β=97.782(8)° γ=90.00°
7-(4-fluorophenyl)-3-methylpyrido[2,3-<i>d</i>]pyrimidine- 2,4(1<i>H</i>,3<i>H</i>)-dione
C14H10FN3O2
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=6.7658(8)Å b=12.978(2)Å c=13.162(2)Å
α=90.00° β=90.00° γ=90.00°
C15H13N3O3
C15H13N3O3
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=6.6312(11)Å b=6.8121(15)Å c=27.653(7)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>,4<i>S</i>)-7-Bromo-2-phenyl-2,3,4,5-tetrahydro-1,4- epoxynaphtho[1,2-<i>b</i>]azepine
C20H16BrNO
Acta Crystallographica Section C (2009) 65, 4 o140-o145
a=7.8444(3)Å b=9.8146(4)Å c=10.0871(4)Å
α=90.00° β=92.103(3)° γ=90.00°
4-Hydroxy-2-vinyl-2,3,4,5-tetrahydro-1-benzazepine
C12H15NO
Acta Crystallographica Section C (2009) 65, 3 o92-o96
a=10.3466(13)Å b=7.488(3)Å c=13.227(9)Å
α=90.00° β=92.94(2)° γ=90.00°
7-chloro-4-hydroxy-2-vinyl-2,3,4,5-tetrahydro-1-benzazepine
C12H14ClNO
Acta Crystallographica Section C (2009) 65, 3 o92-o96
a=11.0850(7)Å b=7.4214(10)Å c=13.4588(11)Å
α=90.00° β=94.721(8)° γ=90.00°
2-amino-6-anilino-4-methoxy-5-[(E)-4-nitrobenzylideneamino]pyrimidine dimethyl sulfoxide solvate
C18H16N6O3,C2H6OS
Acta Crystallographica Section C (2009) 65, 3 o111-o114
a=8.0386(8)Å b=10.6862(14)Å c=12.8856(13)Å
α=71.007(11)° β=74.463(9)° γ=88.672(12)°
(2RS,4SR)-7-bromo-2-(4-chlorophenyl-2,3,4,5-tetrahydro- 1,4-epoxynaphtho[1,2-<i>b</i>]azepine
C20H15BrClNO
Acta Crystallographica Section C (2009) 65, 4 o140-o145
a=9.7758(16)Å b=9.8211(14)Å c=33.174(3)Å
α=90.000° β=90.000° γ=90.000°
(2RS,4SR)-2-(4-fluorophenyl)-2,3,4,5-tetrahydro-1,4- epoxynaphtho[1,2-<i>b</i>]azepine
C20H16FNO
Acta Crystallographica Section C (2009) 65, 4 o140-o145
a=11.3036(4)Å b=12.7585(5)Å c=11.1730(3)Å
α=90.00° β=109.137(2)° γ=90.00°
3-{[4-Amino-6-methoxy-2-(methylsulfanyl)pyrimidin-5-yl]amino}-1,2'- biindenylidene-1',3'-dione dimethyl sulfoxide solvate
C24H18N4O3S,C2H6OS
Acta Crystallographica Section C (2009) 65, 5 o229-o232
a=10.6056(5)Å b=10.9946(11)Å c=12.6770(11)Å
α=69.780(13)° β=76.523(5)° γ=64.484(7)°
Piperidinium 6-amino-3-methyl-5-nitroso-2,4-dioxo-1,2,3,tetrahydropyrimidin-1-ide 6-amino-3-methyl-5-nitrosopyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C5H12N,C5H5N4O3,C5H6N4O3
Acta Crystallographica Section C (2009) 65, 5 o257-o260
a=9.3287(19)Å b=13.1352(10)Å c=16.2814(19)Å
α=87.815(10)° β=74.095(10)° γ=89.987(16)°
(9<i>E</i>)-9-Benzylidene-2-methylsulfanyl-5-phenyl-6,7,8,9-tetrahydropyrimido[4,5-<i>b</i>]quinolin-4(3<i>H</i>)-one
C25H21N3OS
Acta Crystallographica Section C (2013) 69, 12 1524-1526
a=9.2168(16)Å b=9.7617(18)Å c=12.6839(17)Å
α=77.688(16)° β=75.951(11)° γ=68.117(13)°
(<i>E</i>)-1-[(5-Chloro-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)methylidene]-2-phenylhydrazine
C17H15ClN4
Acta Crystallographica Section C (2014) 70, 2 216-219
a=11.773(2)Å b=9.9525(18)Å c=13.760(3)Å
α=90.00° β=114.519(10)° γ=90.00°
7-Benzyl-3-<i>tert</i>-butyl-1-phenyl-6,7-dihydro-1<i>H</i>,4<i>H</i>-\ pyrazolo[3,4-<i>d</i>][1,3]oxazine
C22H25N3O
Acta Crystallographica Section C (2009) 65, 8 o423-o430
a=8.8930(10)Å b=11.1321(12)Å c=10.2078(9)Å
α=90.00° β=109.749(7)° γ=90.00°
3-<i>tert</i>-butyl-7-(4-methoxybenzyl)-1-phenyl-6,7-dihydro- 1<i>H</i>,4<i>H</i>-pyrazolo[3,4-<i>d</i>][1,3]oxazine
C23H27N3O2
Acta Crystallographica Section C (2009) 65, 8 o423-o430
a=9.1888(2)Å b=11.4499(3)Å c=9.7210(2)Å
α=90.00° β=101.8570(10)° γ=90.00°
3-<i>tert</i>-butyl-1-phenyl-7-[4-(trifluoromethyl)benzyl]-6,7-dihydro- 1<i>H</i>,4<i>H</i>-pyrazolo[3,4-<i>d</i>][1,3]oxazine
C23H24F3N3O
Acta Crystallographica Section C (2009) 65, 8 o423-o430
a=9.0277(11)Å b=9.8597(12)Å c=12.6835(18)Å
α=85.531(11)° β=74.180(11)° γ=67.162(9)°
3-<i>tert</i>-butyl-7-(2,3-dimethoxybenzyl)-1-phenyl-6,7-dihydro- 1<i>H</i>,4<i>H</i>-pyrazolo[3,4-<i>d</i>][1,3]oxazine
C24H29N3O3
Acta Crystallographica Section C (2009) 65, 8 o423-o430
a=8.8268(10)Å b=11.6521(10)Å c=10.3831(7)Å
α=90.00° β=93.747(9)° γ=90.00°
3-<i>tert</i>-butyl-1-phenyl-7-(3,4,5-trimethoxybenzyl)-6,7-dihydro- 1<i>H</i>,4<i>H</i>-pyrazolo[3,4-<i>d</i>][1,3]oxazine
C25H31N3O4
Acta Crystallographica Section C (2009) 65, 8 o423-o430
a=9.8189(10)Å b=10.0499(8)Å c=12.8130(14)Å
α=68.710(9)° β=72.537(8)° γ=70.982(8)°
3-<i>tert</i>-butyl-7-(3,4-methylenedioxybenzyl)-1-phenyl-6,7-dihydro- 1<i>H</i>,4<i>H</i>-pyrazolo[3,4-<i>d</i>][1,3]oxazine
C23H25N3O3
Acta Crystallographica Section C (2009) 65, 8 o423-o430
a=9.1164(14)Å b=11.3303(18)Å c=19.694(2)Å
α=90.00° β=99.775(13)° γ=90.00°
2-Amino-3-methyl-6-[methyl(phenyl)amino]-5-nitropyrimidin-4(3<i>H</i>)-one
C12H13N5O3
Acta Crystallographica Section C (2009) 65, 9 o441-o443
a=9.158(2)Å b=12.178(3)Å c=11.103(2)Å
α=90.00° β=105.207(18)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-2-<i>exo</i>-(2-Chlorophenyl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C16H14ClNO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=8.8558(19)Å b=7.3585(13)Å c=9.9622(18)Å
α=90.00° β=101.622(17)° γ=90.00°
5-Nitro-<i>N</i>^4^,<i>N</i>^6^-diphenylpyrimidine-4,6-diamine
C16H13N5O2
Acta Crystallographica Section C (2009) 65, 9 o438-o440
a=7.9112(11)Å b=5.5582(6)Å c=30.665(3)Å
α=90.00° β=94.541(10)° γ=90.00°
6-(1,3-benzodioxol-5-yl)-6,7-dihydro-5<i>H</i>-1,3- dioxolo[4,5-<i>g</i>]quinolin-8-one
C17H13NO5
Acta Crystallographica Section C (2009) 65, 7 o326-o330
a=12.9403(4)Å b=7.1310(2)Å c=14.7736(7)Å
α=90.00° β=103.7580(13)° γ=90.00°
3-<i>tert</i>-butyl-7-(4-nitrobenzyl)-1-phenyl-6,7-dihydro- 1<i>H</i>,4<i>H</i>-pyrazolo[3,4-<i>d</i>][1,3]oxazine
C22H24N4O3
Acta Crystallographica Section C (2009) 65, 8 o423-o430
a=19.164(2)Å b=8.7781(7)Å c=11.7188(12)Å
α=90.00° β=101.717(10)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-2-<i>exo</i>-(2-Chloro-6-fluorophenyl)-2,3,4,5- tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C16H13ClFNO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=9.0768(13)Å b=10.9461(9)Å c=12.9971(18)Å
α=90.00° β=99.768(9)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-7-methyl-2-<i>exo</i>-(4-methylphenyl)- 2,3,4,5-tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C18H19NO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=9.7687(9)Å b=10.3022(17)Å c=14.239(2)Å
α=90.00° β=108.222(10)° γ=90.00°
C17H16ClNO
C17H16ClNO
Acta Crystallographica Section C (2009) 65, 9 o465-o469
a=8.7150(9)Å b=10.406(2)Å c=15.312(4)Å
α=99.547(19)° β=90.621(14)° γ=96.514(13)°
7-bromo-2-exo-phenyl-2,3,4,5-tetrahydro-1<i>H</i>-1,4- epoxy-1-benzazepine
C16H14BrNO
Acta Crystallographica Section C (2010) 66, 4 o233-o240
a=5.5214(3)Å b=10.2982(12)Å c=22.900(3)Å
α=90.00° β=90.00° γ=90.00°